Garrett Wealth Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Garrett Wealth Advisory Group's PFE Position: Q2 2025 in Review
Garrett Wealth Advisory Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 20,135 shares — an estimated $510K sold.
Garrett Wealth Advisory Group first reported a position in PFE in Q4 2018 and held it in 13 quarters. The position peaked at $622K in Q4 2023. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Garrett Wealth Advisory Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Garrett Wealth Advisory Group sold 20,135 Pfizer shares in Q2 2025, an estimated $510K.
- Garrett Wealth Advisory Group first reported a position in Pfizer in Q4 2018 and held it in 13 quarters.
- Garrett Wealth Advisory Group's Pfizer position peaked at $622K in Q4 2023.
- 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Garrett Wealth Advisory Group's 13F filing for Q2 2025, filed 12 Aug 2025.